Skip to main content
×
×
Home

Catatonia

  • Sebastian Walther (a1) and Werner Strik (a1)
Abstract

One of the most exciting psychiatric conditions is the bizarre psychomotor syndrome called catatonia, which may present with a large number of different motor signs and even vegetative instability. Catatonia is potentially life threatening. The use of benzodiazepines and electroconvulsive therapy (ECT) has been efficient in the majority of patients. The rich clinical literature of the past has attempted to capture the nature of catatonia. But the lack of diagnostic clarity and operationalization has hampered research on catatonia for a long time. Within the last decades, it became clear that catatonia had to be separated from schizophrenia, which was finally accomplished in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). In DSM-5, catatonia syndrome may be diagnosed as a specifier to major mood disorders, psychotic disorders, general medical conditions, and as catatonia not otherwise specified. This allows diagnosing the syndrome in a large variety of psychiatric disorders. Currently, the pathobiology remains widely unknown. Suspected neurotransmitter systems include gamma-aminobutyric acid (GABA) and glutamate. Neuroimaging reports pointed to reduced resting state activity and reduced task activation in motor areas of the frontal and parietal cortex. The new classification of catatonia will foster more clinical research and neuroscientific approaches by testing catatonia in various populations and applying stringent criteria. The scarce number of prospective trials will hopefully increase, as more trials will be encouraged within a more precise concept of catatonia.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Catatonia
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Catatonia
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Catatonia
      Available formats
      ×
Copyright
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/4.0/>. The written permission of Cambridge University Press must be obtained for commercial re-use.
Corresponding author
*Address for correspondence: Sebastian Walther, MD, Translational Research Center, University Hospital of Psychiatry Bern, Bolligenstrasse 111, 3000 Bern 60, Switzerland. (Email: walther@puk.unibe.ch)
Footnotes
Hide All

We thank Prof. Andrea Federspiel and Dr. Katharina Stegmayer for preparing the figure.

Footnotes
References
Hide All
1. Kahlbaum, K. Die Katatonie oder das Spannungsirresein. Eine klinische Form psychischer Krankheit. Vol Erstdruck Berlin: A. Hirschwald; 1874.
2. Fink, M, Taylor, MA. The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry. 2009; 66(11): 11731177.
3. Heckers, S, Tandon, R, Bustillo, J. Catatonia in the DSM—shall we move or not? Schizophr Bull. 2010; 36(2): 205207.
4. Ungvari, GS, Caroff, SN, Gerevich, J. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr Bull. 2010; 36(2): 231238.
5. Walther, S, Strik, W. Motor symptoms and schizophrenia. Neuropsychobiology. 2012; 66(2): 7792.
6. Stompe, T, Ortwein-Swoboda, G, Ritter, K, Schanda, H, Friedmann, A. Are we witnessing the disappearance of catatonic schizophrenia? Compr Psychiatry. 2002; 43(3): 167174.
7. Fink, M, Shorter, E, Taylor, MA. Catatonia is not schizophrenia: Kraepelin’s error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull. 2010; 36(2): 314320.
8. Sienaert, P, Dhossche, DM, Vancampfort, D, De Hert, M, Gazdag, G. A clinical review of the treatment of catatonia. Front Psychiatry. 2014; 5: 181.
9. Peralta, V, Campos, MS, de Jalon, EG, Cuesta, MJ. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication. Schizophr Res. 2010; 118(1–3): 168175.
10. van der Heijden, FM, Tuinier, S, Arts, NJ, Hoogendoorn, ML, Kahn, RS, Verhoeven, WM. Catatonia: disappeared or under-diagnosed? Psychopathology. 2005; 38(1): 38.
11. Ungvari, GS, Leung, SK, Ng, FS, Cheung, HK, Leung, T. Schizophrenia with prominent catatonic features (‘catatonic schizophrenia’): I. Demographic and clinical correlates in the chronic phase. Prog Neuropsychopharmacol Biol Psychiatry. 2005; 29(1): 2738.
12. Kruger, S, Bagby, RM, Hoffler, J, Braunig, P. Factor analysis of the catatonia rating scale and catatonic symptom distribution across four diagnostic groups. Compr Psychiatry. 2003; 44(6): 472482.
13. Wing, L, Shah, A. Catatonia in autistic spectrum disorders. Br J Psychiatry. 2000; 176(4): 357362.
14. Dhossche, DM, Wachtel, LE. Catatonia is hidden in plain sight among different pediatric disorders: a review article. Pediatr Neurol. 2010; 43(5): 307315.
15. Tandon, R, Heckers, S, Bustillo, J, et al. Catatonia in DSM-5. Schizophr Res. 2013; 150(1): 2630.
16. Fink, M. Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr Scand. 2013; 127(Suppl 441): 147.
17. Northoff, G, Koch, A, Wenke, J, et al. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord. 1999; 14(3): 404416.
18. Lin, CC, Huang, TL. Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. Compr Psychiatry. 2013; 54(8): 12101214.
19. Bush, G, Petrides, G, Francis, A. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr Res. 1997; 27(1): 8392.
20. Ungvari, GS, Chiu, HF, Chow, LY, Lau, BS, Tang, WK. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology (Berl). 1999; 142(4): 393398.
21. Ungvari, GS, Leung, CM, Wong, MK, Lau, J. Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand. 1994; 89(4): 285288.
22. Raffin, M, Zugaj-Bensaou, L, Bodeau, N, et al. Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry. 2015; 24(4): 441449.
23. Stuivenga, M, Morrens, M. Prevalence of the catatonic syndrome in an acute inpatient sample. Front Psychiatry. 2014; 5: 174.
24. Wilson, JE, Niu, K, Nicolson, SE, Levine, SZ, Heckers, S. The diagnostic criteria and structure of catatonia. Schizophr Res. 2015; 164(1–3): 256262.
25. Bush, G, Fink, M, Petrides, G, Dowling, F, Francis, A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996; 93(2): 129136.
26. Grover, S, Chakrabarti, S, Ghormode, D, Agarwal, M, Sharma, A, Avasthi, A. Catatonia in inpatients with psychiatric disorders: a comparison of schizophrenia and mood disorders. Psychiatry Res. 2015; 229(3): 919925.
27. Peralta, V, Cuesta, MJ. Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr Res. 2001; 47(2–3): 107116.
28. Kleinhaus, K, Harlap, S, Perrin, MC, et al. Catatonic schizophrenia: a cohort prospective study. Schizophr Bull. 2012; 38(2): 331337.
29. Peralta, V, Cuesta, MJ. Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia. Schizophr Res. 2001; 47(2–3): 117126.
30. Krishna, KR, Maniar, RC, Harbishettar, VS. A comparative study of “idiopathic catatonia” with catatonia in schizophrenia. Asian J Psychiatr. 2011; 4(2): 129133.
31. Worku, B, Fekadu, A. Symptom profile and short term outcome of catatonia: an exploratory clinical study. BMC Psychiatry. 2015; 15: 164.
32. Peralta, V, Campos, MS, De Jalon, EG, Cuesta, MJ. Motor behavior abnormalities in drug-naive patients with schizophrenia spectrum disorders. Mov Disord. 2010; 25(8): 10681076.
33. Peralta, V, Cuesta, MJ. The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: a naturalistic study with haloperidol, risperidone, or olanzapine.. Prim Care Companion J Clin Psychiatry. 2010; 12(2): PCC.09m00799.
34. Compton, MT, Fantes, F, Wan, CR, Johnson, S, Walker, EF. Abnormal movements in first-episode, nonaffective psychosis: dyskinesias, stereotypies, and catatonic-like signs. Psychiatry Res. 2015; 226(1): 192197.
35. Ungvari, GS, Goggins, W, Leung, SK, Gerevich, J. Schizophrenia with prominent catatonic features (‘catatonic schizophrenia’). II. Factor analysis of the catatonic syndrome. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(2): 462468.
36. Consoli, A, Raffin, M, Laurent, C, et al. Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study. Schizophr Res. 2012; 137(1–3): 151158.
37. Ghaziuddin, N, Dhossche, D, Marcotte, K. Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatr Scand. 2012; 125(1): 3338.
38. Docx, L, Morrens, M, Bervoets, C, et al. Parsing the components of the psychomotor syndrome in schizophrenia. Acta Psychiatr Scand. 2012; 126(4): 256265.
39. Walther, S, Vanbellingen, T, Muri, R, Strik, W, Bohlhalter, S. Impaired pantomime in schizophrenia: association with frontal lobe function. Cortex. 2013; 49(2): 520527.
40. Walther, S, Stegmayer, K, Sulzbacher, J, et al. Nonverbal social communication and gesture control in schizophrenia. Schizophr Bull. 2015; 41(2): 338345.
41. Ungvari, GS. Amineptine treatment of persistent catatonic symptoms in schizophrenia: a controlled study. Neuropsychopharmacol Hung. 2010; 12(4): 463467.
42. Lauer, M, Schirrmeister, H, Gerhard, A, et al. Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET. J Neural Transm. 2001; 108(6): 661670.
43. Northoff, G. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. J Neural Transm. 2002; 109(12): 14531467.
44. Gouzoulis-Mayfrank, E, Heekeren, K, Neukirch, A, et al. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Pharmacopsychiatry. 2005; 38(6): 301311.
45. Mohn, AR, Gainetdinov, RR, Caron, MG, Koller, BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 1999; 98(4): 427436.
46. Dalmau, J, Lancaster, E, Martinez-Hernandez, E, Rosenfeld, MR, Balice-Gordon, R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10(1): 6374.
47. Steiner, J, Walter, M, Glanz, W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry. 2013; 70(3): 271278.
48. Northoff, G, Steinke, R, Czcervenka, C, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry. 1999; 67(4): 445450.
49. Pettingill, P, Kramer, HB, Coebergh, JA, et al. Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization. Neurology. 2015; 84(12): 12331241.
50. Walther, S. Psychomotor symptoms of schizophrenia map on the cerebral motor circuit. Psychiatry Res. 2015; 233(3): 293298.
51. Northoff, G, Steinke, R, Nagel, DC, et al. Right lower prefronto-parietal cortical dysfunction in akinetic catatonia: a combined study of neuropsychology and regional cerebral blood flow. Psychol Med. 2000; 30(3): 583596.
52. Galynker, II, Weiss, J, Ongseng, F, Finestone, H. ECT treatment and cerebral perfusion in catatonia. J Nucl Med. 1997; 38(2): 251254.
53. Satoh, K, Suzuki, T, Narita, M, et al. Regional cerebral blood flow in catatonic schizophrenia. Psychiatry Res. 1993; 50(4): 203216.
54. Escobar, R, Rios, A, Montoya, ID, et al. Clinical and cerebral blood flow changes in catatonic patients treated with ECT. J Psychosom Res. 2000; 49(6): 423429.
55. Northoff, G, Pfennig, A, Krug, M, et al. Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia. Schizophr Res. 2000; 44(3): 193211.
56. Northoff, G, Braus, DF, Sartorius, A, et al. Reduced activation and altered laterality in two neuroleptic-naive catatonic patients during a motor task in functional MRI. Psychol Med. 1999; 29(4): 9971002.
57. Payoux, P, Boulanouar, K, Sarramon, C, et al. Cortical motor activation in akinetic schizophrenic patients: a pilot functional MRI study. Mov Disord. 2004; 19(1): 8390.
58. Scheuerecker, J, Ufer, S, Kapernick, M, et al. Cerebral network deficits in post-acute catatonic schizophrenic patients measured by fMRI. J Psychiatr Res. 2009; 43(6): 607614.
59. Northoff, G, Kotter, R, Baumgart, F, et al. Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation. Schizophr Bull. 2004; 30(2): 405427.
60. Richter, A, Grimm, S, Northoff, G. Lorazepam modulates orbitofrontal signal changes during emotional processing in catatonia. Hum Psychopharmacol. 2010; 25(1): 5562.
61. Tsujino, N, Nemoto, T, Yamaguchi, T, et al. Cerebral blood flow changes in very-late-onset schizophrenia-like psychosis with catatonia before and after successful treatment. Psychiatry Clin Neurosci. 2011; 65(6): 600603.
62. De Tiege, X, Bier, JC, Massat, I, et al. Regional cerebral glucose metabolism in akinetic catatonia and after remission. J Neurol Neurosurg Psychiatry. 2003; 74(7): 10031004.
63. Grignon, S, Forget, K, Durand, M, Huppert, T. Increased left prefrontal activation during staring/mutism episodes in a patient with resistant catatonic schizophrenia: a near infrared spectroscopy study. Cogn Behav Neurol. 2008; 21(1): 4145.
64. Strik, W, Wopfner, A, Horn, H, et al. The Bern psychopathology scale for the assessment of system-specific psychotic symptoms. Neuropsychobiology. 2010; 61(4): 197209.
65. Stegmayer, K, Horn, H, Federspiel, A, et al. Supplementary motor area (SMA) volume is associated with psychotic aberrant motor behaviour of patients with schizophrenia. Psychiatry Res. 2014; 223(1): 4951.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

CNS Spectrums
  • ISSN: 1092-8529
  • EISSN: 2165-6509
  • URL: /core/journals/cns-spectrums
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed